Pharma VC Funds

Launch Africa Ventures is a leading pan-African venture capital firm focused on addressing the funding gap for seed and pre-Series A startups across the continent. Founded in 2020 by Zachariah George and Janade du Plessis, Launch Africa has rapidly become one of the most active investors in the region. The firm has made significant investments in over 133 startups through its first fund, which raised $36.3 million by March 2022, and continues its momentum with a second fund that has invested $4.3 million into 16 startups across 11 African countries. Notable investments from Launch Africa include Bitmama, BFree, Chekkit, djamo, Gozem, Julaya, and Kuda. They focus on sectors such as fintech, logistics, health tech, and clean energy. Recent investments from their second fund feature startups like Servisor, Credit Circuit, and Shiprazor in South Africa; Lengo, Paps, and Solarbox in Senegal; Logistify and Octavia Carbon in Kenya; and Periculum and Kredete in Nigeria. Launch Africa's investment strategy emphasizes founder diversity, market potential, and geographical reach, supporting startups that have gone through renowned accelerator programs and display strong growth prospects. This approach not only helps in scaling these ventures but also contributes to the broader economic development of the African continent.

LaunchCapital, established in 2008, focuses on seed-stage investments and is backed by the Pritzker/Vlock Family Office. The firm has invested in over 200 companies, enabling entrepreneurs to build innovative businesses across various industries. Notable portfolio companies include Snapchat, Life360, and Formlabs, demonstrating their broad investment scope from consumer apps to advanced technology​​. LaunchCapital provides substantial support to its portfolio companies, emphasizing mentorship and strategic guidance. They typically invest during a company's first or second round of institutional funding and continue to support these companies through significant follow-on investments. Their approach is characterized by a commitment to milestones, capital efficiency, and a focus on developing both the entrepreneur and the business​​. With offices in Boston, New Haven, New York, and San Francisco, LaunchCapital maintains a national presence, ensuring they can support founders across the country. The firm's hands-on approach and strong network of advisors and entrepreneurs make it a valuable partner for startups looking to scale​.

Launchpad Venture Group is a prominent angel investment firm based in Boston, Massachusetts, focusing on early-stage technology and life science startups in the New England area. Since its inception in 2001, the firm has invested over $125 million in more than 150 startups, offering both financial support and human capital to foster growth and innovation. The firm’s portfolio includes a variety of sectors such as e-commerce, enterprise technology, healthcare, green technology, and education. Notable current investments include companies like ezCater, a corporate catering platform; Qstream, a mobile sales enablement and analytics tool; and RaySecur, which specializes in mail security through 3D scanning technology. Past successful exits include acquisitions of EnergySage by Schneider Electric and Localytics by Upland Software. Launchpad is renowned for its active angel network, providing startups with mentorship, strategic advice, and access to a wide range of industry connections. They focus on building long-term relationships with their portfolio companies, helping them scale and succeed in competitive markets​.

Lauxera Capital Partners is a healthcare-focused investment firm, specializing in growth-stage companies that are scientifically de-risked and have clear commercial pathways. Founded in 2020, the firm operates from Paris and San Francisco, with a focus on innovative healthcare sectors like medical devices, digital health, diagnostics, life sciences tools, and healthcare IT. They invest when startups have a proven revenue model and are ready to scale, contributing both capital and strategic expertise. Lauxera manages over €260 million through its Lauxera Growth I fund and typically invests between €300,000 and €3 million per startup. The firm is known for its hands-on approach, leveraging the operational experience of its team to support management in overcoming growth challenges and optimizing market adoption. Notable investments include Natural Cycles and Caresyntax, highlighting their commitment to cutting-edge health technologies​. Lauxera’s global perspective and strong European roots, combined with its healthcare expertise, make it a valuable partner for startups aiming to scale in large healthcare markets​.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.

Left Lane Capital is a prominent venture capital firm headquartered in Brooklyn, New York, with an additional office in London. Founded in 2019, the firm specializes in investing in high-growth internet and consumer technology companies. Their mission is to support companies that are driving the digitization of the real economy by providing them with actionable insights and operational support to achieve hyper-scale growth. The firm's investment portfolio includes notable companies such as GoStudent, Jackpocket, and Bilt Rewards. GoStudent is a Vienna-based digital marketplace for online tutoring, Jackpocket is a mobile lottery platform, and Bilt Rewards is a consumer finance and rewards company focused on property renters. Other significant investments include Talkiatry, a behavioral healthcare company, and Blinkist, a service that provides key insights from non-fiction books in audio and text formats. Left Lane Capital typically invests between $5 million and $75 million, often leading or co-leading rounds. They focus on sectors such as fintech, healthtech, e-commerce enablement, and SaaS, supporting both B2B and B2C business models. The firm prides itself on a data-driven approach and a deep understanding of their portfolio companies' markets and customers. The team is led by founder and CEO Harley Miller, along with managing partners Avneet Pujji, Daniel Ahrens, and Jason Fiedler. They bring extensive experience and a commitment to working closely with founders to navigate the challenges of scaling businesses.

Legend Capital, established in 2001, is a leading venture capital and private equity firm in China. The firm focuses on early-stage and growth-stage investments, managing over $10 billion in commitments. With a strong presence in Beijing, Shanghai, Shenzhen, Hong Kong, Seoul, and Singapore, Legend Capital has invested in around 600 companies across various sectors. Some of their notable investments include Pony.ai, which focuses on autonomous driving technology, and Beijing ESWIN Technology Group, a key player in semiconductor products and services. Legend Capital also supports companies like ZongmuTech in autonomous driving and Atour, a lifestyle accommodation brand. Additionally, they have invested in prominent companies like Bilibili, a leading video community, and Tuhu, an automotive consumer service platform. Legend Capital has a significant footprint in the life sciences sector, with portfolio companies like Recbio, a novel vaccines company, and Pharmaron, a leading contract research organization. Their investments are characterized by a focus on innovative technologies and solutions that drive industry advancements and address critical needs in the market. The firm is committed to providing comprehensive support to its portfolio companies, including governance, business strategy, R&D resources, and financial backing, helping them to scale and achieve long-term success.

Lerer Hippeau is a prominent seed-stage venture capital firm based in New York City. Founded in 2010, it has built a strong reputation for backing early-stage startups with transformative potential. The firm has invested in over 400 companies, including notable successes like Warby Parker, Allbirds, BuzzFeed, Oscar Health, and ClassDojo. Their portfolio spans various sectors, with significant investments in consumer products, enterprise software, healthcare, fintech, and media. Lerer Hippeau's investment strategy focuses on partnering with innovative founders and providing extensive support to help them grow. They typically invest in seed and early-stage rounds but also participate in follow-on investments to support the continued growth of their portfolio companies. The firm is known for its hands-on approach and deep network, which they leverage to help startups scale. Key figures at Lerer Hippeau include managing partners like Ben Lerer, Eric Hippeau, and Graham Brown, who bring a wealth of experience and industry insight. The firm is recognized for fostering a collaborative and founder-friendly culture, making it a preferred choice for many early-stage entrepreneurs looking for more than just capital. Lerer Hippeau’s notable unicorns include SeatGeek, ClassDojo, and Genies, among others. The firm has also seen several successful IPOs, including companies like Allbirds and Warby Parker, further establishing its reputation as a leading early-stage investor. For startups aiming to connect with Lerer Hippeau, it's beneficial to showcase innovative solutions with strong market potential, aligning with the firm’s focus on supporting transformative and high-growth ventures​.

LetsVenture, established in 2013, is a prominent platform in India's private market investment ecosystem, focusing on early-stage startups. The platform has facilitated over 900 investments, raising more than $250 million for startups, and is backed by notable figures like Ratan Tata and Mohandas Pai. LetsVenture supports a wide array of sectors including e-commerce, software, healthcare, and food and beverage. The platform's investment strategy includes seed and series A rounds, with significant investments in companies like Testbook.com, Innov8 Coworking, and Scripbox. LetsVenture operates through various verticals such as LetsVenture Early Stage, which connects investors with disruptive early-stage startups, and LetsVenture Debt, providing loans to startups for growth. They also offer trica equity, a solution for managing equity, cap tables, and ESOPs. LetsVenture has a robust network of over 20,000 investors and 500 family offices and VCs, making it a vital player in the Indian startup ecosystem. The platform also organizes the annual LetsIgnite event, one of India’s largest conclaves for startup investors, fostering connections and growth within the community​.

Lewis & Clark Ventures is an early-stage venture capital firm based in St. Louis, Missouri, specializing in B2B software investments. Founded by former founders and operators, the firm leverages its team's extensive entrepreneurial experience to partner with dynamic founders aiming to build successful companies. They focus on late seed to Series A investments, typically ranging from $2 million to $3 million per initial investment. The firm's portfolio includes innovative companies like Beam Benefits, Benson Hill, and GreenLight Biosciences. Lewis & Clark Ventures is known for its hands-on approach, often taking board seats and providing strategic, technical, and commercial support to help their portfolio companies scale effectively. Their investment strategy targets high-growth opportunities in overlooked geographies, emphasizing the importance of founder vision, team strength, and market potential. The firm values transparency, smart growth, and long-term partnerships, aiming to support founders not just with capital but also with mentorship and access to their extensive networks.

LG Technology Ventures, founded in 2018 and based in Santa Clara, California, is the corporate venture capital arm of LG Group. The firm focuses on investing in early-stage companies across various sectors, including artificial intelligence, information technology, automotive, life sciences, and energy. With over $400 million in managed assets, LG Technology Ventures aims to drive innovation and growth by partnering with promising startups. Their portfolio includes notable investments in companies like H2O.ai, which offers an open-source machine learning platform; The Sandbox, a virtual metaverse game; and Moloco, which provides AI-enabled mobile DSP software. They have also invested in Element Energy, a battery technology company, and Eatron Technologies, specializing in AI for automotive and electric vehicles​​. The team at LG Technology Ventures consists of experienced investors, technologists, and industry experts, led by Dong-Su Kim, Ph.D., who serves as the CEO. The firm is known for its strategic approach, often leading investment rounds and providing substantial support to its portfolio companies to help them scale and succeed globally.​

Lifeline Ventures, based in Helsinki, Finland, is a prominent early-stage venture capital firm co-founded by Petteri Koponen and Timo Ahopelto. Lifeline Ventures is sector-agnostic but has a strong emphasis on health, climate tech, hardware, software, and marketplaces. They focus on investing in resilient founders who aim to become industry leaders. The firm has made significant investments in companies such as Wolt, which was acquired by DoorDash, and Supercell, a gaming giant. Other notable investments include Enevo, Dispelix, and Iceye, showcasing their diverse portfolio and commitment to high-impact sectors. They typically lead funding rounds with check sizes ranging from €300K to €3M, supporting startups from pre-seed to Series B stages. Geographically, Lifeline Ventures primarily invests in startups across Finland, but their reach extends to other parts of Europe and the United States. Their strategy emphasizes deep involvement with their portfolio companies, providing not only capital but also strategic guidance and operational support. The Lifeline Ventures team consists of seasoned entrepreneurs and industry experts, leveraging their extensive experience to help founders navigate the complexities of scaling their businesses. Startups looking to engage with Lifeline Ventures should present innovative solutions with strong growth potential, as the firm is keen on backing companies that can make a substantial impact in their respective industries.

Lightspeed Venture Partners is a prominent global venture capital firm that focuses on seed, early, and growth-stage investments across various sectors, including enterprise, fintech, consumer, and healthcare. Established in 2000, Lightspeed has raised significant capital over the years, including $4.2 billion in 2020 across three funds: an $890 million early-stage fund, a $1.83 billion growth fund, and a $1.5 billion opportunity fund. The firm has a robust portfolio with notable investments in companies like Snap, Nutanix, and Zscaler, reflecting its success in backing high-growth tech startups. Lightspeed has also been instrumental in the growth of other leading companies such as Affirm, MuleSoft, and The Honest Company. Their global reach includes offices in the United States, Israel, India, China, Southeast Asia, and Europe, enabling them to support entrepreneurs worldwide. Lightspeed's investment philosophy centers on deep engagement with their portfolio companies, offering not only capital but also strategic guidance and operational support. This hands-on approach helps startups navigate the challenges of scaling and achieving market leadership. Their commitment to building long-term relationships with founders and their focus on creating enduring companies sets them apart in the venture capital landscape.

Life.SREDA is a Singapore-based venture capital firm, established in 2012, that focuses exclusively on fintech investments. It was one of the first non-corporate VC funds to specialize in fintech, making significant strides in shaping the fintech landscape across Asia and globally. The firm has raised two major funds: Life.SREDA I ($40 million) and Life.SREDA II Asia ($100 million), which have enabled investments in over 20 fintech startups. These include well-known names like Simple, Moven, and Fidor, which are recognized for disrupting traditional financial services. Life.SREDA also manages the BB Fund, a blockchain-focused investment vehicle launched in 2016, further expanding its reach into emerging technologies. The fund targets companies involved in blockchain and cryptocurrency, reflecting its commitment to staying at the forefront of financial innovation. The firm's investment strategy focuses on early-stage companies in the fintech space, helping to nurture them through their growth stages and leading to multiple successful exits, such as Allset Technologies and Life Pay. Life.SREDA has built a reputation as a major player in the Asian fintech ecosystem and continues to invest in companies that are transforming financial services through technology.

LifeForce Capital, founded in 2015 and based in San Francisco, specializes in investing in healthcare companies that are advancing care delivery through innovative technologies and new care models. They focus on digital health startups that enable new therapeutic development and efficient care delivery. Some of their notable investments include Notable Labs, which leverages AI for precision oncology, Clover Health, a technology-driven health insurance company, and One Medical, a membership-based primary care platform. LifeForce Capital targets early to late-stage ventures, with a typical investment ranging from seed to Series B. They emphasize a software-first approach, aiming to drive a paradigm shift in healthcare. Their strategy involves supporting companies that offer scalable solutions with significant potential for improving patient outcomes and healthcare efficiency. The firm has a solid track record with successful exits such as Cricket Health and TARA Biosystems. The investment team, led by founder John Noonan, includes experts like Dr. Dora Hughes and Nathaniel Bays, who bring extensive experience in healthcare investment and operations. For entrepreneurs, LifeForce Capital looks for groundbreaking innovations that align with their mission to reshape healthcare. Startups are advised to present clear, impactful solutions that demonstrate potential for significant advancements in care delivery and therapeutic development​.

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

HV Ventures, also known as Lighthouse Ventures, is a venture capital firm based in Prague, Czech Republic, that focuses on early-stage investments. The firm is particularly active in the Central and Eastern European (CEE) region, supporting startups in sectors like financial services, logistics, and enterprise technology. Notable investments include 4Trans, Persoo, and AhoyConnect. LHV Ventures typically invests in seed and Series A rounds, with initial investments ranging from €200,000 to €3 million. They provide not only financial backing but also professional support through their extensive network and expertise in entrepreneurship, startup mentoring, and mergers and acquisitions. The firm is highly active in the local startup ecosystem, often co-investing with other prominent funds and leveraging support from initiatives like the Czech ESIF Fund of Funds to nurture promising startups. Key team members include Managing Partner Michal Zálešák, who brings a wealth of experience and leadership to the firm. LHV Ventures' approach emphasizes deep involvement with portfolio companies, helping them navigate challenges and scale effectively. Entrepreneurs looking to pitch to LHV Ventures should focus on demonstrating strong market potential and innovative solutions, particularly those that can scale globally from their base in the CEE region. The firm values thorough preparation and a clear understanding of the market dynamics. Overall, LHV Ventures is committed to fostering growth in the CEE startup ecosystem through strategic investments and active engagement with founders and their teams.

Lightrock is a global private equity firm that focuses on investing in sustainable businesses led by purpose-driven entrepreneurs. The firm aims to drive systemic change at scale through innovation, aligning its investments with impact themes such as "people," "planet," and "productivity/tech for good." Founded under the umbrella of LGT, Lightrock is committed to creating positive societal and environmental returns alongside financial gains​. Lightrock's diverse portfolio includes over 60 high-growth companies worldwide. Notable investments include Infarm, a rapidly growing urban farming network; PharmEasy, a leading omni-channel healthcare platform in India; and M-Kopa, a pioneer in pay-as-you-go solar energy services for off-grid customers in East Africa​. The firm actively supports its portfolio companies, often taking board positions to guide their dynamic growth and expansion. Headquartered in London, Lightrock operates globally with a team of more than 55 investment professionals across four continents, encompassing extensive experience in impact investing, leadership, and entrepreneurship. The firm is led by CEO Pal Erik Sjatil, the former Managing Partner of McKinsey & Company Europe​.

Lightspeed Venture Partners, founded in 2000, is a prominent global venture capital firm based in Menlo Park, California. The firm specializes in multi-stage investments, supporting companies from seed to growth stages. Lightspeed's investment focus spans several sectors, including enterprise, consumer, fintech, and healthcare. Some of Lightspeed's notable investments include Snapchat, Affirm, and Rubrik. Snapchat, a popular social media platform, went public in 2017, marking a significant success for the firm. Affirm, a financial technology company, also achieved a successful IPO in 2021. Rubrik, a leader in cloud data management, is another key company in their portfolio that highlights Lightspeed's focus on disruptive technology. Lightspeed Venture Partners has raised substantial funds over the years to support its diverse portfolio. In 2020, the firm raised $4.2 billion across three funds: an early-stage venture fund, a growth fund for later-stage investments, and an opportunity fund for doubling down on successful investments. The firm's philosophy centers on deep commitment and collaboration with founders, providing not just capital but also strategic guidance and support to help build enduring companies. With a global presence and a history of backing innovative companies, Lightspeed continues to be a key player in the venture capital landscape.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Listen Ventures, based in Chicago, is a venture capital firm dedicated to investing in consumer-focused brands. Founded in 2010, Listen Ventures operates with a unique approach by combining capital with brand strategy, creativity, and consumer insights to help entrepreneurs build impactful brands. The firm has raised $92 million across two funds: Listen Ventures III, a $62 million core fund for early-stage investments, and Listen Up, a $30 million opportunity fund for later-stage investments in its existing portfolio. Notable investments include brands like Calm, Catch Co, Dame, Factor, and Interior Define​. Listen Ventures emphasizes a concentrated investment strategy, preferring to invest larger amounts of capital and resources into fewer companies. This allows them to provide comprehensive support, including strategic and creative guidance. Their investment thesis centers on identifying shifts in cultural narratives and consumer behavior, backing brands that address these shifts effectively.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LiveOak Venture Partners, based in Austin, Texas, is a prominent venture capital firm dedicated to investing in early-stage tech and tech-enabled service companies primarily within Texas. Founded in 2012 by Krishna Srinivasan and Venu Shamapant, LiveOak has successfully positioned itself as a leading VC firm focused on nurturing Texas-based startups. The firm has raised three major funds, with the latest being a $210 million Fund III, which surpassed its initial target of $150 million. This makes it the largest Texas-focused early-stage VC fund raised in the past decade. LiveOak's investment strategy is centered on leading or co-leading seed, Series A, and occasionally pre-seed and growth-stage investments, with initial checks ranging from $500K to $10M. They focus on sectors like healthcare technology, information technology, and tech-enabled services. LiveOak's portfolio includes notable companies such as DISCO, OJO Labs, Digital Pharmacist, and Opcity. These companies have either achieved successful exits or have continued to grow under LiveOak’s guidance. The firm prides itself on being deeply involved with its portfolio companies, providing strategic advice, leveraging a vast network, and assisting in crucial hires and growth strategies. LiveOak's commitment to Texas is evident not only in its investment focus but also in its community initiatives like LiveOak Gives, which supports local non-profit organizations. This hands-on, community-oriented approach has helped LiveOak foster a thriving entrepreneurial ecosystem in Texas, contributing significantly to the region's economic growth.

LocalGlobe, founded by Robin and Saul Klein in 1999, is a leading venture capital firm based in London. The firm focuses on seed and early-stage investments, typically investing $0-1 million. LocalGlobe has built a strong reputation for supporting startups from their inception to successful Series A rounds, often within 15 to 18 months. LocalGlobe is known for its hands-on approach, leveraging a network of industry experts and mentors to help portfolio companies navigate early-stage challenges. The firm looks for founders with a strong vision and passion for their industry, prioritizing solutions that address significant real-world problems. This strategy has led to investments in some of the most transformative companies, such as fintech giants, digital banking solutions, and innovative technology firms. Their focus is primarily on the UK market, deploying about 80% of their capital locally. This commitment to nurturing local talent has solidified their position as one of the most influential seed investors in Europe. LocalGlobe's approach and strategic investments have significantly impacted the global startup ecosystem, making them a crucial player in the venture capital landscape.

Locus Ventures is a seed-stage venture capital firm founded by alumni from Google, Facebook, and Y Combinator. The firm focuses on investing in early-stage startups with the potential to create significant impact in various industries. Notable companies in their portfolio include Meesho, an online reselling platform; Ironclad, a contract lifecycle management software; and GitLab, a prominent DevOps platform that went public in 2021. Locus Ventures primarily invests in startups within the U.S. and Asia, leveraging their extensive experience and network in Silicon Valley and beyond. Their investment strategy emphasizes close collaboration with founders, providing guidance on product development and market strategy. They are known for their hands-on approach, often leading seed rounds and participating actively in the growth of their portfolio companies. The firm is led by partners Eric Kwan, William Chan, Perry Tam, and Tommy Tsai, who bring diverse backgrounds in technology and entrepreneurship. Locus Ventures has a track record of successful exits, including acquisitions by major companies such as Stripe and Nestlé.

Long Journey Ventures, founded in 2019 and based in San Francisco, focuses on early-stage investments across various sectors, including enterprise applications, consumer products, and emerging technologies. The firm has built an impressive portfolio featuring notable companies like Affirm, Uber, SpaceX, and Carta. They have also invested in innovative startups such as Flexport, Grove Collaborative, and Checkr. Long Journey Ventures typically invests in seed and Series A rounds, with an average round size of $17 million. Their strategy includes both leading and participating in funding rounds, providing strategic support and leveraging their extensive network to help startups scale. The firm has successfully nurtured nine unicorns, including Together AI, Crusoe, and Density. The leadership team includes experienced professionals like Cyan Banister, Lee Jacobs, and Arielle Zuckerberg, who bring deep expertise in venture investing and a strong track record of successful exits. Long Journey Ventures has been active with recent investments in sectors like satellite communication (Northwood Space) and cloud security (LimaCharlie), highlighting their commitment to supporting groundbreaking technologies and innovative business models.

LongeVC is a venture capital firm specializing in early-stage investments in biotechnology, with a strong focus on longevity and age-related innovations. Based in Lugano, Switzerland, and Latvia, the firm targets breakthrough startups in sectors like biotech, life sciences, and therapeutics that aim to extend human health and longevity. LongeVC typically invests between €0.5 million and €2.3 million in companies across Europe, the U.S., and Israel. The firm is backed by a deep scientific advisory board and meticulously prioritizes scientific due diligence. Their portfolio includes leading biotech startups such as Insilico Medicine, known for AI-driven drug discovery, and Longenesis, which provides tools for collaborative biotech research. LongeVC's mission is to bring life-changing health technologies to market, addressing global challenges like aging and healthcare. Led by partners like Ilya Suharenko and Garri Zmudze, LongeVC offers not only capital but also strategic business development support, helping founders build scalable businesses that can make a global impact.

Longevity Vision Fund (LVF) is a venture capital firm based in New York City, founded by Sergey Young. The fund focuses on investing in technologies and companies that aim to extend healthy human lifespans and address the negative effects of aging. With a $100 million fund, LVF supports innovations in preventive medicine, early detection, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. LVF's mission is to accelerate breakthroughs in longevity and make these advancements more accessible and affordable to the general public. Notable investments include Senda Biosciences, a company dedicated to developing treatments through its proprietary molecular platform. The fund is led by Sergey Young, a prominent figure in the longevity space with over 20 years of investment experience. Other key team members include Avetik Arakelyan, Sourav Sinha, and Kris Verburgh, who bring diverse expertise in healthcare, technology, and finance. LVF targets early-stage investments and partners with innovative companies worldwide, aiming to transform the life sciences and healthcare industries. They emphasize a long-term commitment to improving human health and promoting a healthier, longer life for everyone.

Longitude Capital is a healthcare-focused venture capital firm that invests across biotechnology, medical technology, and health solutions sectors. Established in 2006, the firm seeks out transformative companies that can improve clinical outcomes, enhance quality of life, and drive healthcare efficiencies. They invest across various stages, from startups to growth companies, with a unique focus on areas like oncology, neurodegenerative diseases, aging, and cardiovascular solutions. Longitude's approach is flexible, allowing them to invest in early clinical-stage companies, spin-outs, and even publicly traded firms. The firm is known for its involvement in special situations, including recapitalizations and PIPEs (Private Investment in Public Equity). They have a proven track record with successful IPOs and acquisitions, such as Aimmune Therapeutics, KaNDy Therapeutics, and Axonics Modulation Technologies. With $585 million raised in its latest fund (LVP4), Longitude Capital's strategy remains rooted in long-term value creation, bolstered by robust internal research teams. Their offices are located in Menlo Park, Greenwich, and Boston, and they continue to partner with both emerging and established healthcare innovators.

Longwall Ventures is a UK-based venture capital firm specializing in early-stage investments in the health, resilience, and sustainability sectors. Founded with a mission to support innovative startups, Longwall Ventures has a strong focus on companies that leverage science and engineering to create impactful solutions. Notable investments by Longwall Ventures include Wayland Additive, which develops advanced 3D printing technologies; Lightcast Discovery, a biotechnology firm; and Caristo Diagnostics, which focuses on cardiovascular diagnostics. The firm has also invested in Closed Loop Medicine, a company developing personalized drug and digital therapy combinations, and LettUs Grow, which specializes in vertical farming technology. Longwall Ventures is known for its hands-on approach, providing not only capital but also strategic support to its portfolio companies. With a diverse portfolio of over 40 companies, Longwall Ventures continues to play a crucial role in fostering innovation and supporting the growth of early-stage companies in the UK and beyond.

Longwood Fund, founded in 2010 and based in Boston, Massachusetts, is a venture capital firm specializing in creating and investing in science-based companies that develop novel solutions to address important medical needs. The fund's principals have co-founded 25 companies, serving as CEOs, Chief Business Officers, and lead investors, and have helped advance over 20 products to market. Longwood Fund's portfolio includes several notable companies such as Grail, which focuses on early cancer detection, and TScan Therapeutics, which develops novel T cell therapies for cancer. Other significant investments include Immunitas Therapeutics, a company using single-cell genomics to innovate in immune oncology, and Be Biopharma, which is developing engineered B cells as a new category of cellular medicines. The fund emphasizes a value-add investment approach, actively supporting its portfolio companies in accelerating clinical progress from lab to patient. With a strong track record of successful exits, including Pyxis Oncology and PTC Therapeutics, Longwood Fund continues to play a pivotal role in advancing healthcare innovations.

Lonza is a global leader in the life sciences industry, providing contract development and manufacturing services (CDMO) for the pharmaceutical, biotech, and nutrition sectors. With headquarters in Basel, Switzerland, Lonza operates over 50 sites worldwide, offering end-to-end solutions across biologics, small molecules, cell and gene therapies, and more. In addition to its CDMO services, Lonza is deeply involved in venture capital through strategic partnerships and investments. The company collaborates with venture capital firms like ALSA Ventures and Bioqube Ventures to support emerging biotech startups, focusing on developing innovative therapies. Lonza's role in these partnerships often includes early-stage de-risking, development, and manufacturing services, helping startups navigate the complexities of bringing new treatments to market. Lonza has also launched a venture capital fund with Prolog Ventures to invest in North American health and wellness startups. This fund is part of Lonza's broader strategy to foster innovation in the health sector by supporting companies that align with its mission to improve patient outcomes and address unmet medical needs​.

Loup Ventures is a Minneapolis and New York-based venture capital firm focused on frontier technologies, including artificial intelligence (AI), augmented reality (AR), virtual reality (VR), and robotics. Founded in 2017 by Andrew Murphy, Doug Clinton, and Gene Munster, the firm invests primarily in early-stage companies that are at the intersection of these emerging technologies. Loup Ventures is research-driven, leveraging in-depth analysis and insights to guide its investment decisions. Notable investments include Neurable, an AI company advancing brain-computer interfaces, and Skupos, a platform providing data solutions for convenience stores. The firm is known for its focus on high-impact sectors like neurotechnology, and the future of transportation, with its portfolio companies aiming to shape the way humans interact with machines and the digital world. Geographically, Loup Ventures focuses on investments across the U.S., with its team frequently engaging in thought leadership through articles and podcasts on technological trends. Their investment strategy emphasizes deep involvement, supporting founders not only financially but also with insights derived from their rigorous market research. The team, led by Gene Munster, a well-known tech analyst, and Andrew Murphy, brings extensive experience in tech and finance. Loup Ventures prefers a hands-on approach, often leading rounds and staying actively involved in guiding startups to scale. Startups looking to attract their attention should highlight disruptive tech in AI or AR, showcasing robust market research and a clear vision for the future.

Lowercarbon Capital, founded in 2018 by Chris and Crystal Sacca, is a venture capital firm dedicated to combating climate change through investments in innovative technologies. Based in Jackson, Wyoming, the firm focuses on backing companies that reduce CO2 emissions, remove existing carbon from the atmosphere, and develop solutions to mitigate the impacts of climate change. Notable investments include Lilac Solutions, which is revolutionizing lithium extraction; Solugen, which produces chemicals using enzymes instead of oil; Commonwealth Fusion Systems, working on fusion energy; and Mosa Meat, creating lab-grown meat to reduce livestock emissions. Lowercarbon Capital has invested in over 160 companies, aiming to combine hard science with ambitious goals to tackle climate challenges. The firm’s strategy emphasizes both financial returns and environmental impact, supporting startups from the R&D stage to seed funding with checks ranging from $50,000 to $1 million. Their comprehensive approach includes not only capital but also strategic guidance and support for founders through a robust ecosystem of industry experts and fellow entrepreneurs​. Led by a team of experienced investors and scientists, including managing partner Chris Sacca, Lowercarbon Capital is positioned at the forefront of climate tech innovation, making significant strides in various sectors such as energy, agriculture, and industrial materials.

Lowercase Capital, founded by Chris Sacca in 2010, is a renowned venture capital firm based in San Francisco. The firm specializes in early-stage investments and has built a notable portfolio featuring some of the most successful tech startups of the past decade. Their investments include iconic companies such as Twitter, Uber, Instagram, Twilio, Stripe, and Kickstarter. These high-profile successes have helped establish Lowercase Capital as a significant player in the venture capital landscape. Lowercase Capital has made around 250 investments, spanning various industries including technology, media, and consumer products. They are particularly known for their involvement in Y Combinator companies, investing in startups like 9gag, Stripe, and Docker. The firm's strategy involves not only providing capital but also offering extensive support and guidance to their portfolio companies, leveraging Chris Sacca's extensive experience and network within the tech industry. The firm's notable exits include Slack, Instagram, and Twitter, which have contributed significantly to Lowercase Capital's reputation and financial success. These exits highlight the firm's ability to identify and nurture companies with substantial growth potential. Lowercase Capital is also known for its philanthropic efforts, supporting startups that empower and help people in need, such as charity: water and the Anti-Recidivism Coalition. Chris Sacca, the founder, has been recognized for his impactful contributions to both the business and philanthropic sectors, making him a prominent figure in the venture capital community.

Loyal VC is a global venture fund established in 2018 that operates a startup index fund with over 350 investments across more than 60 countries. The firm is known for its unique gate-stage investment process, which reduces systemic bias and aims to unlock greater returns. This process involves multiple rounds of diligence and quarterly redemptions, offering flexibility to high-net-worth individuals and institutions. Loyal VC collaborates closely with INSEAD, Founder Institute, and a network of over 1,000 advisors. This extensive network supports a diverse portfolio of founders, with more than 30% of the portfolio companies led by women CEOs and nearly 30% based in emerging markets. The firm places a strong emphasis on social impact, with 80% of its investments aligned with one or more of the UN Sustainable Development Goals (SDGs). Notable investments by Loyal VC include Sama, a company that brings transparency and verifiability to cross-border blue-collar recruitment, and TechStyle, a digital marketplace for sustainable material sourcing in the fashion industry. The firm also supports companies like CurieMD, a telemedicine platform for menopause care, and Milestone, a financial literacy app aimed at helping parents raise financially responsible children. Loyal VC’s investment focus spans various sectors, including cleantech, fintech, healthcare, and more, reflecting their commitment to backing innovative solutions across the globe. For more information, you can visit their official website.

Ludlow Ventures, founded in 2009 and based in Detroit, Michigan, is a venture capital firm that takes a unique approach to investing by emphasizing strong personal relationships with entrepreneurs. The firm focuses on early-stage investments, particularly in the technology sector. Ludlow Ventures has built a robust portfolio, with notable companies such as Honey, a browser extension for online shopping deals acquired by PayPal; Wag, a dog-walking service; and Product Hunt, a platform for discovering new products. The firm has made over 160 investments and has achieved 24 exits, showcasing their ability to identify and support high-potential startups. Other significant investments include Headout, an on-demand mobile platform for booking tours and activities, and CoverTree, an insurtech company focused on property insurance. Ludlow Ventures operates with a philosophy of "VC without ego," striving to be collaborative and supportive partners to their portfolio companies. The team, led by Managing Partner Jonathon Triest, prides itself on being deeply involved in the success of the startups they back, providing not just capital but also strategic advice and resources.

Lumira Ventures is a prominent venture capital firm specializing in life sciences and healthcare investments. Established in 1989 and headquartered in Toronto, Canada, Lumira Ventures has a robust presence across North America, with offices in Toronto, Montreal, Vancouver, and Boston. The firm focuses on backing innovative biotechnology and medical technology companies that have the potential to address significant unmet medical needs and improve healthcare quality globally. The firm's investment portfolio includes a wide range of companies such as Depomed, Guava Technologies, Think Research, and U-Systems, showcasing their diverse interest in biopharmaceuticals and medical devices. Notable recent investments include Antiva Biosciences, developing topical therapies for HPV-related pre-cancerous lesions, and Arclight Therapeutics, focusing on neurodegenerative diseases. Lumira Ventures' investment strategy involves providing substantial support to their portfolio companies, from early-stage funding to strategic guidance. They recently closed their Lumira Ventures IV fund at $220 million, the largest life sciences venture fund ever raised in Canada, highlighting their significant role in the sector. Overall, Lumira Ventures is dedicated to advancing healthcare innovation through strategic investments and active support of pioneering companies in the life sciences domain.

LUMO Labs is a dynamic venture capital firm based in Eindhoven, Netherlands, that prioritizes impact-driven investments in emerging digital technologies. Focused on pre-seed to Series A stages, LUMO Labs targets startups in fields like AI, blockchain, robotics, IoT, and AR/VR. The firm is deeply committed to supporting innovations that address global challenges related to sustainable cities, health, well-being, and education. Its portfolio includes companies such as Alphabeats, Enliven, and Roboat, all of which push the boundaries of technology while contributing to societal progress. Founded by Andy Lürling and Sven Bakkes, LUMO Labs has gained recognition for its hands-on approach. Startups in their portfolio benefit from a two-year venture builder program, which provides personalized coaching, access to expert networks, and support tailored to each company's unique needs. This program focuses on four key pillars: leadership, product-market fit, storytelling, and follow-on investment, ensuring that startups scale effectively both economically and socially. With the recent launch of the €100 million LUMO Rise Fund, LUMO Labs has expanded its scope across Europe, investing in climate action, digital security, and projects aligned with the UN’s Sustainable Development Goals. LUMO Labs is driven by the belief that technological advancements can serve as powerful tools for creating a better and more sustainable future.

Lux Capital is a leading venture capital firm renowned for its investments in groundbreaking science and technology ventures. With a portfolio boasting companies like Recursion Pharmaceuticals, Desktop Metal, and Matterport, Lux Capital focuses on industries such as biotechnology, material science, and artificial intelligence. The firm invests primarily in early-stage startups but is versatile enough to support companies through later stages as well. Lux Capital is geographically centered in the United States, with a strong presence in New York and Silicon Valley. Their investment strategy is defined by backing counter-conventional ideas that push the boundaries of current technology and science. They are known for making substantial investments, often leading funding rounds, and providing robust support to their portfolio companies to ensure their long-term success. The firm is managed by an experienced team including co-founders Peter Hébert, Robert Paull, and Joshua Wolfe. Their approach is hands-on, offering not just capital but also strategic guidance, networking opportunities, and operational support. Lux Capital values innovative pitches and prefers to be approached with well-researched and transformative ideas. In recent years, Lux Capital has been highly active, raising significant funds like the $1.15 billion for its eighth fund. The firm’s commitment to pioneering technologies is evident in their diverse investments, from AI-driven biotech firms like Evolutionary Scale to innovative aerospace companies like Planet.

M Ventures, the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany, was established in 2009. The fund focuses on investments in biotechnology, healthcare, life science tools, electronics, and frontier technologies aimed at sustainability. With a dual focus on strategic and financial returns, M Ventures has a broad investment portfolio that targets transformational ideas and innovative solutions. M Ventures has committed €600 million to support its investments, allowing it to back both early-stage and more advanced companies. The fund has a strong track record with over 115 deals and 86 portfolio startups. Notable investments include companies like Artios Pharma, which focuses on DNA damage response therapies for cancer, and Storm Therapeutics, which specializes in RNA modulation. The venture capital arm takes an active role in its portfolio companies, collaborating closely with entrepreneurs and co-investors to drive innovation and commercial success. M Ventures' strategy includes making early-stage investments and helping companies develop technologies that align with Merck’s long-term R&D goals.

M12, Microsoft's venture fund, focuses on early-stage investments, primarily in Series A and B rounds. Established in 2016, M12 has quickly become a significant player in the venture capital landscape, leveraging Microsoft's extensive network and resources to support its portfolio companies. M12's investment areas include AI, cloud infrastructure, cybersecurity, developer tools, vertical SaaS, and emerging technologies like Web3 and gaming. Notable investments by M12 include companies such as SpaceX, Addepar, GoPuff, BitGo, and Dataminr. Additionally, M12 has backed promising startups like BlueVine in vertical SaaS, Bolster in cybersecurity, and Bonsai in AI. M12 also focuses on fostering innovative solutions in autonomous systems and frontier technologies​. The fund operates with a close alignment to Microsoft, which allows it to provide unique benefits and opportunities for its portfolio companies, such as integrations with Microsoft Azure and other enterprise solutions. This strategic alignment helps startups accelerate their growth and expand their market reach by leveraging Microsoft's extensive ecosystem.

M13 is a venture capital firm based in Santa Monica, California, known for its early-stage investments in disruptive technology and consumer-focused companies. Founded in 2016 by brothers Carter and Courtney Reum, M13 has established a robust portfolio that includes notable companies such as Ring, Cue, Daily Harvest, FabFitFun, ClassPass, Matterport, and Capsule. M13's investment strategy spans several sectors including health, commerce, work, and money, with a strong focus on infrastructure technologies such as AI and web3. The firm leverages its Propulsion Platform, which combines operational expertise and strategic guidance to help startups scale efficiently. This platform ensures that each founder receives tailored support, significantly enhancing their chances of success. M13 has recently launched its third fund, raising $400 million to continue backing early-stage teams. Their approach involves writing checks of up to $15 million from Seed to Series B stages, often leading the investment rounds. This fund aims to capitalize on the evolving consumer behavior and the growing importance of horizontal technology layers, including blockchain-based applications governed through tokens.

M25 is an early-stage venture capital firm based in Chicago, focusing on investments in startups headquartered in the Midwest. Founded in 2015, M25 has quickly become one of the most active seed investors in the region, with over 90 investments across a variety of industries, including AI, fintech, e-commerce, healthcare, and software. Notable investments from M25 include companies like Upsie, a warranty services provider; Avail, a platform for landlords and tenants; and PactSafe, a contract acceptance platform. The firm has a strong focus on supporting innovative and high-growth potential startups, leveraging their extensive network and resources to help these companies scale effectively. M25’s investment strategy involves making initial investments ranging from $500,000 to $1.5 million and often taking board seats to provide strategic guidance. The firm emphasizes a data-driven approach to investment decisions and maintains a hands-on relationship with its portfolio companies to support their growth and success.

MaC Venture Capital, co-founded by Adrian Fenty, Marlon Nichols, Michael Palank, and Charles D. King, is a prominent seed-stage venture capital firm headquartered in Los Angeles and Silicon Valley. The fund focuses on investing in technology startups that leverage cultural shifts and trends. Notable investments include Gimlet Media, Truebill, Pipe, Edge Delta, Stoke, Zigazoo, and Spartan Radar, reflecting their strategic emphasis on technology, fintech, media, and mobile sectors. MaC VC is distinguished by its commitment to diversity; 36% of their portfolio companies are led by women, and 69% by BIPOC founders. Their investment strategy centers on backing early-stage companies with innovative solutions addressing large market needs. They typically lead rounds and write initial checks of significant amounts, maintaining substantial reserves to support follow-on investments in high-performing portfolio companies. The firm’s team, which includes key figures like Adrian Fenty and Marlon Nichols, brings a wealth of expertise across technology, politics, entertainment, and finance. This diverse leadership enhances their ability to provide comprehensive support in operations, brand building, and strategic introductions, crucial for scaling startups.\

Madrona Venture Group, founded in 1995 and based in Seattle, Washington, focuses on early-stage and seed investments, particularly in the Pacific Northwest. The firm is known for its commitment to long-term partnerships with entrepreneurs, supporting them through the entire lifecycle from idea inception to market success. Madrona has a strong presence in sectors such as AI, intelligent applications, cloud computing, and enterprise software​. Madrona's investment philosophy, "Day One for the Long Run," emphasizes sustained engagement and strategic support. This approach has contributed to the success of companies like Smartsheet and Rover. Smartsheet, for example, overcame significant challenges during the 2008 financial crisis with Madrona's support, eventually going public in 2018. The firm has made over 550 investments, including in prominent companies like Snowflake, Redfin, and Apptio. Recent investments include Tektonic AI and Vilya, reflecting Madrona's focus on emerging technologies and innovative startups​. Madrona's team includes experienced professionals like Matt McIlwain and Scott Jacobson, who bring deep industry expertise and a hands-on approach to working with portfolio companies. This strong partnership ethos and strategic guidance have positioned Madrona as a key player in the venture capital landscape.

Magnetic Ventures is a Miami Beach-based venture capital firm founded in 2018 by Christine Aylward. The firm specializes in early-stage investments, primarily focusing on companies at the intersection of technology and life sciences. With a strong emphasis on AI, machine learning, and biotech, Magnetic Ventures backs founders who are developing transformative solutions in healthcare. Their investment portfolio includes cutting-edge companies like Deep Genomics, Spotlight Therapeutics, and Paradigm, which are revolutionizing areas like drug discovery, gene editing, and clinical research. Magnetic Ventures typically makes initial investments ranging from $1 million to $6 million, entering at seed or Series A stages. The firm is deeply involved in supporting its portfolio companies throughout their growth, leveraging its extensive experience in healthcare regulation and commercialization. Their geographical focus is North America and Europe, with offices in Miami, Boston, and Research Triangle Park​. This hands-on approach and a mission to advance patient care through technology have made Magnetic Ventures a key player in driving innovation across the healthcare landscape.